Pharming Group N.V. PHAR
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 213.43% | 187.56% | 124.08% | 102.14% | 38.46% |
| Total Depreciation and Amortization | 11.80% | 58.45% | 1.30% | -2.92% | -4.26% |
| Total Amortization of Deferred Charges | 4.81% | 4.81% | 4.81% | -3.62% | -3.62% |
| Total Other Non-Cash Items | -45.56% | 14.00% | 233.40% | 229.03% | 152.51% |
| Change in Net Operating Assets | -4.20% | 223.75% | 203.11% | 191.17% | 78.80% |
| Cash from Operations | 12.82% | 827.48% | 3,147.80% | 11,725.28% | 638.65% |
| Capital Expenditure | 27.15% | 28.93% | 5.19% | 36.72% | -21.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | 100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -206.27% | -168.10% | 160.67% | 93.93% | 427.09% |
| Cash from Investing | -501.95% | -267.79% | -16.97% | -55.98% | 184.56% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.25% |
| Total Debt Repaid | -282.37% | 88.07% | 96.94% | 96.80% | 96.89% |
| Issuance of Common Stock | 594.01% | 375.08% | 255.14% | 345.64% | -72.24% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 33.51% | 18.95% | -139.01% | -234.57% | -90.85% |
| Cash from Financing | 94.68% | 97.39% | 104.34% | 94.74% | 50.62% |
| Foreign Exchange rate Adjustments | -112.02% | 3,738.64% | 458.11% | 181.26% | 1,290.16% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 47.26% | -194.06% | 1,429.42% | 1,093.34% | 177.65% |